Please login to the form below

Not currently logged in
Email:
Password:

IMI

This page shows the latest IMI news and features for those working in and with pharma, biotech and healthcare.

IMI calls for advancements in machine learning and digital clinical trials

IMI calls for advancements in machine learning and digital clinical trials

The Innovative Medicines Initiative (IMI) is pursing the development of machine learning and digital clinical trials with its latest round of funding. ... The IMI said that vast amounts of data generated during drug discovery is not always “used

Latest news

More from news
Approximately 11 fully matching, plus 31 partially matching documents found.

Latest Intelligence

  • A quest for innovative solutions A quest for innovative solutions

    The innovative Medicines Initiative (IMI), with 5.3bn invested in 90 projects, is a barometer of the industry’s deep dive into technology at a time when ageing populations with multiple

  • Cubist: Meeting the challenge in antibiotics Cubist: Meeting the challenge in antibiotics

    There are a number of collaborations we have with biotech companies in Europe, but regarding the IMI collaboration, it is too early yet for discussion.”. ... Several other companies are signed up to the IMI's efforts in AMR, including GlaxoSmithKline,

  • Interview: Georg Toufar, Mundipharma Interview: Georg Toufar, Mundipharma

    of working with local academics, while the Innovative Medicines Initiative (IMI) is bringing EFPIA members together with academics and biotechs to research major public health problems.

  • Interview: Harvey Berger and Timothy Clackson, Ariad Interview: Harvey Berger and Timothy Clackson, Ariad

    clinical data or the EC-backed Innovative Medicines Initiative (IMI).

  • VIDEO interview: Neil Weir, UCB VIDEO interview: Neil Weir, UCB

    is chair of the Innovative Medicines Initiative (IMI) – a partnership between the European Commission (EC) and industry trade body the European Federation of Pharmaceutical Industries and Associations (EFPIA) to encourage collaboration ... UCB is

More from intelligence
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Innovative Medicines Initiative appoints executive director Innovative Medicines Initiative appoints executive director

    Innovative Medicines Initiative (IMI) has named Pierre Meulien as executive director, effective from September. ... Pierre Meulien's invaluable experience will help IMI deliver on its ambitious objectives.”.

  • IMI picks Ipsen's Marc de Garidel to chair governing board IMI picks Ipsen's Marc de Garidel to chair governing board

    Its second-phase IMI 2 programme aims to develop next generation vaccines, medicines and treatments, such as new antibiotics. ... I am confident that his decades of experience working in the pharmaceutical sector will prove invaluable to IMI.”.

  • IMI appoints new chair of scientific committee IMI appoints new chair of scientific committee

    Prof Maria Beatriz da Silva Lima has been elected chair of the Scientific Committee of the Innovative Medicines Initiative (IMI). ... Finally, there is huge potential to expand the principles underlying IMI to the rest of the world.”.

  • Hans Lennernas joins board of CMO Recipharm Hans Lennernas joins board of CMO Recipharm

    Prof Lennernäs is currently a professor of biopharmaceuticals at Uppsala University in Sweden, where he manages an Innovative Medicines Initiative (IMI) project called OrBiTo, which aims to improve the delivery of

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • The heart of the matter - Part Three

    IMI GetReal, a consortium that includes EMA, HTA bodies, academia, patient organisations and pharma, aims to improve the efficiency of medicine development processes by developing a framework to assess the relative ... RCTs are still the gold standard

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics